Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation

被引:76
作者
Aversa, A. [1 ]
Pili, M.
Francomano, D.
Bruzziches, R.
Spera, E. [2 ]
La Pera, G. [3 ]
Spera, G.
机构
[1] Univ Roma La Sapienza, Dept Med Pathophysiol, Chair Internal Med, DFM, I-00161 Rome, Italy
[2] Univ Roma Tor Vergata, Dept Urol, Rome, Italy
[3] Azienda Osped San Camillo, Rome, Italy
关键词
phosphodiesterase type-5 inhibitor; IELT; PERT; ejaculatory control; treatment; PHOSPHODIESTERASE TYPE-5 INHIBITORS; SEMINAL-VESICLE TISSUE; REFRACTORY TIME; DRUG-TREATMENT; SILDENAFIL; EFFICACY; DEFINITION; VALIDATION; TADALAFIL; RESPONSES;
D O I
10.1038/ijir.2009.21
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Premature ejaculation (PE) is thought to be the most common male sexual dysfunction; however, the prevalence of lifelong (LL)-PE is relatively low. The aim of this study was to investigate the effects of on-demand vardenafil (10 mg) to modify the intravaginal ejaculatory latency time (IELT) in men with LL-PE without erectile dysfunction. Forty-two men (18-35 years) were enrolled in a 16-week, double-blind, placebo-controlled, cross-over study. Primary end point was the modification from baseline of IELT assessed by stopwatch technique; secondary end points were post-ejaculatory refractory time (PERT) and variations of scores at the Index of Premature Ejaculation questionnaire. The changes in geometric mean IELT were superior after taking vardenafil (0.6 +/- 0.3 vs 4.5 +/- 1.1 min, P < 0.01), compared with placebo (0.7 +/- 0.3 vs 0.9 +/- 1.0 min, ns). PERT dropped significantly after vardenafil (16.7 +/- 2.0 vs 4.3 +/- 0.9 min, P < 0.001), compared with placebo (15.3 +/- 2.2 vs 15.8 +/- 2.3 min). Patients who took vardenafil (vs placebo) reported significantly (P < 0.01) increased ejaculatory control (6 +/- 2 vs 16 +/- 2), improved overall sexual satisfaction (7 +/- 2 vs 15 +/- 1) and distress (4 +/- 1 vs 8 +/- 1) scores, respectively. Multiple regression analysis (r(2) = 0.86) for IELT by the number of attempts at sexual intercourse showed significant differences between the slopes of lines for placebo and vardenafil (P < 0.0001). The most common adverse events for vardenafil (vs placebo) were headache (10 vs 3%), flushing (12 vs 0%) and dyspepsia (10 vs 0%), which tended to disappear over the time. In conclusion, in our study, vardenafil increased IELT and reduced PERT in men with LL-PE. Besides, improvements in confidence, perception of ejaculatory control and overall sexual satisfaction were reported. International Journal of Impotence Research (2009) 21, 221-227; doi: 10.1038/ijir.2009.21; published online 28 May 2009
引用
收藏
页码:221 / 227
页数:7
相关论文
共 30 条
[1]   Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation [J].
Althof, S ;
Rosen, R ;
Symonds, T ;
Mundayat, R ;
May, K ;
Abraham, L .
JOURNAL OF SEXUAL MEDICINE, 2006, 3 (03) :465-475
[2]   Effects of sildenafil (Viagra™) administration on seminal parameters and post-ejaculatory refractory time in normal males [J].
Aversa, A ;
Mazzilli, F ;
Rossi, T ;
Delfino, M ;
Isidori, AM ;
Fabbri, A .
HUMAN REPRODUCTION, 2000, 15 (01) :131-134
[3]   Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function [J].
Cappelleri, JC ;
Rosen, RC ;
Smith, MD ;
Mishra, A ;
Osterloh, IH .
UROLOGY, 1999, 54 (02) :346-351
[4]   RELATIONSHIP BETWEEN SYMPATHETIC NERVOUS-SYSTEM ACTIVITY, BAROREFLEX AND CARDIOVASCULAR EFFECTS AFTER ACUTE NITRIC-OXIDE SYNTHESIS INHIBITION IN HUMANS [J].
CASTELLANO, M ;
RIZZONI, D ;
BESCHI, M ;
MUIESAN, ML ;
PORTERI, E ;
BETTONI, G ;
SALVETTI, M ;
CINELLI, A ;
ZULLI, R ;
AGABITIROSEI, E .
JOURNAL OF HYPERTENSION, 1995, 13 (10) :1153-1161
[5]   The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: A critical analysis of basic science and clinical data [J].
Chen, Juza ;
Keren-Paz, Gal ;
Bar-Yosef, Yuval ;
Matzkin, Haim .
EUROPEAN UROLOGY, 2007, 52 (05) :1331-1339
[6]   Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation [J].
Chen, JZ ;
Mabjeesh, NJ ;
Matzkin, H ;
Greenstein, A .
UROLOGY, 2003, 61 (01) :197-200
[7]   Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS-/-) [J].
Kriegsfeld, LJ ;
Demas, GE ;
Huang, PL ;
Burnett, AL ;
Nelson, RJ .
PHYSIOLOGY & BEHAVIOR, 1999, 67 (04) :561-566
[8]   Central regulation of autonomic function: No brakes? [J].
Krukoff, TL .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1998, 25 (06) :474-478
[9]   Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: a randomised, prospective and crossover study [J].
Mathers, M. J. ;
Klotz, T. ;
Roth, S. ;
Luemmen, G. ;
Sommer, F. .
ANDROLOGIA, 2009, 41 (03) :169-175
[10]   Efficacy of sildenafil citrate (viagra) in men with premature ejaculation [J].
McMahon, CG ;
Stuckey, BGA ;
Andersen, M ;
Purvis, K ;
Koppiker, N ;
Haughie, S ;
Boolell, M .
JOURNAL OF SEXUAL MEDICINE, 2005, 2 (03) :368-375